可解释的机器学习用于评估肝移植中供体移植的捐赠者移植
Liang Zhixing1,2, Ye Linsen1,2, Jiang Peng1,2
1Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
概括
一个新的机器学习模型准确地预测了肝移植后延迟的移植功能. 该工具有助于外科医生评估供体肝移植,并通过识别关键风险因素来改善患者的治疗结果.
科学领域:
- 肝病学和移植外科手术
- 人工智能在医学中的应用
- 生物医学数据科学 生物医学数据科学
背景情况:
- 肝移植面临着供体器官的严重短缺,需要精确评估移植的生存能力.
- 预测术后延迟移植功能 (DGF) 对于成功的肝移植结果至关重要.
- 目前用于移植评估的方法需要改进以满足临床需求.
研究的目的:
- 开发和验证一种机器学习 (ML) 模型,用于预测肝移植患者的术后DGF.
- 确定影响DGF预测的关键变量.
- 为了可视化ML模型的决策过程,以获得临床解释性.
主要方法:
- 利用了来自中国10个主要肝移植中心的5242对捐赠者-接受者数据 (2017-2022年).
- 采用递归特征消除,从63个初始参数中选择30个关键变量.
- 开发并验证了ML模型,包括极端梯度提升和后勤回归,使用AUC评估性能,精度,灵敏度和特异性.
主要成果:
- 极端渐变增强模型实现了高预测准确度 (AUC 0.877,内部准确度为 0.936;外部AUC 0.776,准确度为 0.957).
- 对于DGF的关键预测因素包括短 perfusion 时间,高的供体血清,手术内出血,高的供体马-谷氨基甲酸酶和供体血糖.
- 该模型还在预测移植后1个月 (AUC 0.841) 和3个月 (AUC 0.834) 的存活率方面表现强.
结论:
- 开发的ML模型在肝移植中提供了术后DGF的优异预测性能.
- 这种工具可以帮助临床医生更有效地评估供体肝移植.
- 该模型有助于做出明智的决策,可能提高移植成功率.
更多相关视频
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
567
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.1K
相关概念视频
Tissue Transplantation
271
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
271
Bone Marrow Sampling and Transplants
260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260
